Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
Genes|July 27, 2024
In Silico Prediction of BRCA1 and BRCA2 Variants with Conflicting Clinical Interpretation in a Cohort of Breast Cancer PatientsStefania Stella, Silvia Rita Vitale, Michele Massimino, et al.
Anticancer Research|May 6, 2020
ABL1-Directed Inhibitors for CML: Efficacy, Resistance and Future PerspectivesMichele Massimino, Stefania Stella, Elena Tirrò, et al.
Diagnostics (Basel, Switzerland)|August 27, 2021
A Novel System for Semiautomatic Sample Processing in Chronic Myeloid Leukaemia: Increasing Throughput without Impacting on Molecular Monitoring at Time of SARS-CoV-2 PandemicStefania Stella, Silvia Rita Vitale, Michele Massimino, et al.
In Vivo (Athens, Greece)|March 1, 2020
Targeting BCL-2 as a Therapeutic Strategy for Primary -positive B-ALL CellsMichele Massimino, Elena Tirrò, Stefania Stella, et al.
Anticancer Research|December 8, 2019
Detection and Clinical Implications of a Novel BCR-ABL1 E12A2 Insertion/Deletion in a CML Patient Expressing the E13A2 IsoformStefania Stella, Michele Massimino, Elena Tirrò, et al.
International Journal of Molecular Sciences|January 9, 2021
Molecular Pathogenesis and Treatment Perspectives for Hypereosinophilia and Hypereosinophilic SyndromesStefania Stella, Michele Massimino, Livia Manzella, et al.
Oncotargets and Therapy|October 9, 2023
High BCR::ABL1 Expression Defines CD34+ Cells with Significant Alterations in Signal Transduction, Short-Proliferative Potential and Self-Renewal AbilityMichele Massimino, Stefania Stella, Elena Tirrò, et al.
Acta Haematologica|April 10, 2019
Colony-Forming Cell Assay Detecting the Co-Expression of JAK2V617F and BCR-ABL1 in the Same Clone: A Case ReportElena Tirrò, Stefania Stella, Michele Massimino, et al.
Anticancer Research|December 29, 2018
B-ALL Relapses After Autologous Stem Cell Transplantation Associated With a Shift from e1a2 to e14a2 BCR-ABL Transcripts: A Case ReportStefania Stella, Michele Massimino, Elena Tirrò, et al.
Oncology Letters|August 13, 2019
Rapid decline of Philadelphia-positive metaphases after nilotinib treatment in a CML patient expressing a rare e14a3 BCR-ABL1 fusion transcript: A case reportMichele Massimino, Stefania Stella, Elena Tirrò, et al.
Pageof 9